Author(s):
Shaileshkumar K. Koradia, Rushik P. Thakkar
Email(s):
shaileshkoradia.ksp@kpgu.ac.in
DOI:
10.52711/2231-5675.2024.00020 
Address:
Shaileshkumar K. Koradia1*, Rushik P. Thakkar2
1Department of Pharmaceutical Chemistry and Quality Assurance, Krishna School of Pharmacy and Research, Drs. Kiran and Pallavi Patel Global University, Krishna Edu. Campus, Vadodara – Mumbai NH # 8, Varnama, Vadodara- 391243, Gujarat, India.
2Babaria Institute of Pharmacy, BITS Edu. Campus, Vadodara – Mumbai NH # 8, Varnama, Vadodara- 391243, Gujarat, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 3,
Year - 2024
ABSTRACT:
The developed ultraviolet spectrophotometric method allows simple, eco- friendly, accurate and precise determination of anti-cancer agent alectinib hydrochloride in bulk and its pharmaceutical formulation. Alectinib hydrochloride standard drug was dissolved and quantitatively diluted in methanol to produced a solution of 8.0 µg/mL concentration and absorbance was measured at its detection wavelength 339 nm against methanol as reagent blank. The calibration curve obeyed Beer’s law in the concentration range of 2 - 12 µg/mL with correlation co-efficient of 0.9996. The detection limits and quantitation limits were found to be 0.57 µg/mL and 1.71 µg/mL, respectively which indicates method is sensitive. Precision experiment was for intra-day, inter-day and repeatability and %RSD was found to be within the specified limits. The percent recovery studies was performed at three different levels and was observed between 99.56 - 101.43 %, indicating insignificant interference from the other ingredients present in the capsule formulation. The robustness study was performed by deliberately variations in the method parameters and % RSD was calculated and found within the limits indicates that the method is robust. The method validation parameters such as accuracy, precision, linearity, detection limit and quantitation limit of were validated as per international council for harmonization guidelines Q2-R1 and successfully applied for the quantitative analysis of alectinib hydrochloride from its pharmaceutical formulation.
Cite this article:
Shaileshkumar K. Koradia, Rushik P. Thakkar. Ultraviolet spectrophotometric quantitation of anticancer drug alectinib hydrochloride in pharmaceutical formulation using green solvent. Asian Journal of Pharmaceutical Analysis. 2024; 14(3):119-1. doi: 10.52711/2231-5675.2024.00020
Cite(Electronic):
Shaileshkumar K. Koradia, Rushik P. Thakkar. Ultraviolet spectrophotometric quantitation of anticancer drug alectinib hydrochloride in pharmaceutical formulation using green solvent. Asian Journal of Pharmaceutical Analysis. 2024; 14(3):119-1. doi: 10.52711/2231-5675.2024.00020 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2024-14-3-1
REFERENCES:
1. Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: Diagnosis and management. American Family Physician. 2007; 75(1):56-63.
2. Wong SY. Apoptosis in cancer: from pathogenesis to treatment. Journal of Experimental and Clinical Cancer Research. 2011; 30(1): 1-14.
3. Karachaliou N et al. Profile of alectinib for the treat¬ment of alk-positive non-small cell lung cancer (NSCLC): Patient selection and perspectives. Onco Targets and Therapy. 2019; 12(2): 4567-4575. doi: 10.2147/OTT.S174548.
4. Hadir MM et al. Development and validation of UPLC-MS/MS method for the simultaneous quantification of anaplastic lymphoma kinase inhibitors, alectinib, ceritinib, and crizotinib in Wistar rat plasma with application to bromelain-induced pharmacokinetic interaction. Journal of Pharmaceutical and Biomedical Analysis. 2021: 204: 114276. doi: 10.1016/j.jpba.2021.114276.
5. Huang XX et al. An UPLC-MS/MS method for the quantitation of alectinib in rat plasma. Journal of Pharmaceutical and Biomedical Analysis. 2017; 132(4): 227-231. doi: 10.1016/j.jpba.2016.10.010.
6. Kumar HKS et al. A Novel Ultra Performance Liquid Chromatography-PDA Method Development and Validation for Alectinib in Bulk and its Application to Tablet Dosage Form. International Journal of Pharmaceutical Investigation. 2020; 10(4): 537-541. doi: 10.5330/ijpi.2020.4.93
7. Pavani B., Mounica P.: RP-HPLC method development and validation for estima¬tion of Alectinib in bulk and pharmaceutical dosage form. Int J Pharm and anal Res. 2019; 8(3): 293-300.
8. Prashanthi Y., et al. Method Development and Validation of Alec¬tinib Drug by RP-HPLC in Bulk and Pharmaceutical Dosage Form. Asian J. Pharm Anal. 2018; 8(4): 186-90. doi: 10.5958/2231-5675.2018.00034.0
9. G. Kumar et al. A Novel Method Development and Validation for Related Substances of Adapalene in Bulk Drug Product by HPLC. Research J. Pharm. and Tech. 9(12); 2016: 2234-2240. doi: 10.5958/0974-360X.2016.00451.0
10. D.M.Darandale et al. Development and Validation of RP-HPLC Method for the Determination of Febuxostat in Bulk and Pharmaceutical Dosage Form. Asian J. Research Chem. 2017; 10(6): 713-718. doi: 10.5958/0974-4150.2017.00121.3
11. Nidhi K. Patel, Shailesh K. Koradia. Development and Validation of stability indicating RP-HPLC method for the simultaneous estimation of Beclomethasone dipropionate and Formoterol fumarate in their combined pharmaceutical dosage form. Asian J. Pharm. Ana. 2016; 6(2): 83-90. doi: 10.5958/2231-5675.2016.00013.2
12. Shailesh Koradia et al. Separation and Simultaneous Quantitation of Tolterodine Tartrate and Tamsulosin Hydrochloride in Capsule Formulation by using Stability-Indicating RP-HPLC-DAD Method. Research Journal of Pharmacy and Technology. 2021; 14(9): 4561-6. doi: 10.52711/0974-360X.2021.00793
13. Harshal D. Patil et al. A Brief Review on Gas Chromatography. Asian Journal of Pharmaceutical Analysis. 2023; 13(1): 47-2. doi: 10.52711/2231-5675.2023.00008
14. K. Bhavya Sri et al. Two Dimensional Gas Chromatography- A Review. Asian Journal of Pharmaceutical Analysis. 2021; 11(4): 293-6. doi: 10.52711/2231-5675.2021.00050
15. Shailesh Dadge et al. Stability Indicating HPTLC Method for Estimation of Metoprolol Tartrate in Bulk and in Pharmaceutical Formulation. Asian J. Research Chem. 2018; 11(4): 755-762. doi: 10.5958/0974-4150.2018.00133.5
16. Kalyani U. Shelar et al. Stability indicating HPTLC method development and validation for the estimation of celecoxib in bulk drug and its Pharmaceutical formulation. Research J. Pharm. and Tech. 2020; 13(8): 3661-3665. doi: 10.5958/0974-360X.2020.00647.2
17. ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1) Current Step 4 Version, November, 2005.